- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 16/22 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors
Patent holdings for IPC class C07K 16/22
Total number of patents in this class: 3724
10-year publication summary
|
307
|
322
|
375
|
327
|
339
|
340
|
402
|
349
|
310
|
97
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 3650 |
222 |
| Genentech, Inc. | 3742 |
166 |
| F. Hoffmann-La Roche AG | 7958 |
115 |
| Hoffmann-La Roche Inc. | 3060 |
102 |
| Novartis AG | 11238 |
90 |
| Amgen Inc. | 3779 |
74 |
| Scholar Rock, Inc. | 93 |
62 |
| Mayo Foundation for Medical Education and Research | 2981 |
54 |
| Genzyme Corporation | 1205 |
52 |
| Zoetis Services LLC | 1537 |
43 |
| Boehringer Ingelheim International GmbH | 4629 |
40 |
| The Regents of the University of California | 18943 |
39 |
| Acceleron Pharma Inc. | 365 |
36 |
| Xencor, Inc. | 403 |
31 |
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
27 |
| Abbvie Inc. | 1808 |
26 |
| Eli Lilly and Company | 3645 |
26 |
| MedImmune Limited | 627 |
25 |
| Samsung Electronics Co., Ltd. | 131630 |
24 |
| FibroGen, Inc. | 186 |
23 |
| Other owners | 2447 |